Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05023720. IPD Sharing: YES. Countries: 1. Publications: 0.
Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
ClinicalTrials.gov study NCT05794971. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
ClinicalTrials.gov study NCT06425133. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Ge
ClinicalTrials.gov study NCT06949982. IPD Sharing: NO. Countries: 1. Publications: 0.
SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
ClinicalTrials.gov study NCT04803877. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC
ClinicalTrials.gov study NCT05917431. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX
ClinicalTrials.gov study NCT02425683. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT02910843. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours
ClinicalTrials.gov study NCT05644392. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04008511. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05024539. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07392866. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
ClinicalTrials.gov study NCT06095375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer
ClinicalTrials.gov study NCT03627728. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01875380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Optimization for Regorafenib in HCC
ClinicalTrials.gov study NCT04476329. IPD Sharing: NO. Countries: 1. Publications: 0.
WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib
ClinicalTrials.gov study NCT01265979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients
ClinicalTrials.gov study NCT02439723. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial
ClinicalTrials.gov study NCT05382741. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies
ClinicalTrials.gov study NCT06246643. IPD Sharing: NO. Countries: 5. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.